StemCell Therapy

News can be fascinating or frightening. Researchers have managed to hack into evolution by accelerating the transformation of the apes brain into a human-like brain thanks to a gene that increases the number of neural stem cells. The experiment was stopped for ethical reasons, but it still raises many questions about this kind of manipulation.

There are 95% of similarities between humans and chimpanzees. The human genome is therefore very similar to that of certain animals.

What if, thanks to genetic manipulation, apes became as intelligent as humans and competed with them as they did on the Planet of the Apes? The subject has fascinated scientists for years, and a new experiment brings us a little closer to Pierre Boules book, adapted for the cinema in 1968. German and Japanese researchers claim to have hacked into the evolution of the brain by increasing the volume of the neocortex in marmoset embryos.

Seven million years separate the great apes from the first Homo sapiens. A slow development led to an increase in the brain size and changes in its structure, including an increase in the cerebral neocortex. The latter, the youngest part of the cerebral cortex during evolution, is about three times the size of our closest relative, the chimpanzee. It is at the center of cognitive functions such as logical thinking and language. One of the key questions for scientists is how the neocortex was able to become so large and give us our cognitive abilities.

In the study published in the journal Science, Wieland Huttner and his colleagues at the Max Planck Institute for Cell Biology and Molecular Genetics (MPI-CBG) in Dresden have investigated the ARHGAP11B gene. The ARHGAP11B gene is the result of a mutation in the ARHGAP11A gene that occurred approximately 1.5 million years ago along the evolutionary line that led to todays Neanderthals, Denisovans, and humans after the line of descent separated from that of the chimpanzee. This gene encodes a protein known for its ability to increase the production of neural stem cells.

Read Also: Genetics Have Less Effect on Longevity, Calico Study Shows

The mutation in the ARHGAP11B gene from a single C to a G gene letter results in the loss of 55 nucleotides in the formation of the corresponding messenger RNA. This leads to a change in the transcription of the proteins amino acids, explains Wieland Huttner. This mutation seems to have directly influenced human evolution, he adds. By 2015, Huttner had succeeded in increasing the production of brain stem cells in mice, but with a boosted version of the gene. This time, German researchers joined forces with the Central Institute for Experimental Animals (CIEA) in Kawasaki and Keio University in Tokyo, pioneers in the creation of transgenic monkeys, to conduct an experiment with the normal version of the human gene in marmoset fetuses.

A larger, brain with more folding

The gene was implanted into Mykot embryos three to five days after ovulation. They then allowed the embryos to live to 101 days, 50 days before the normal date of birth. This allowed them to see three important developments in the development of the monkey brain:

Read Also: How Your Smartphone Can Reduce Your Brain Power and Harm Your Health

From here to the creation of monkeys that are so intelligent and competitive to humans, many hurdles have to still be overcome. However, to avoid any controversy, the researchers have taken all ethical precautions. It is not a question of working on apes or chimpanzees that are too close to humans, or of completing the birth of genetically modified apes. Wieland Huttner also hints at criticism of the Chinese experiment. It would have been irresponsible to complete the birth of the marmosets because the behavioral changes caused by the alteration of the neocortex are not known, says Huttner. So for the moment, we will not know whether these marmosets could have played chess with us.

Human-specific ARHGAP11B increases size and folding of primate neocortex in the fetal marmoset

Here is the original post:
Planet of the Apes: by Enlarging the Brains of Apes Are Scientists Creating Worthy Opponents to Humans - Gilmore Health News

The causes of aging are extremely complex and unclear. But with longevity clinical trials increasing, more answersand questionsare emerging than ever before.

With the dramatic demonetization of genome reading and editing over the past decade, and Big Pharma, startups, and the FDA starting to face aging as a disease, we are starting to turn those answers into practical ways to extend our healthspan.

In this article, Ill explore how genome sequencing and editing, along with new classes of anti-aging drugs, are augmenting our biology to further extend our healthy lives.

Your genome is the software that runs your body. A sequence of 3.2 billion letters makes you you. These base pairs of As, Ts, Cs, and Gs determine your hair color, your height, your personality, your propensity for disease, your lifespan, and so on.

Until recently, its been very difficult to rapidly and cheaply read these lettersand even more difficult to understand what they mean. Since 2001, the cost to sequence a whole human genome has plummeted exponentially, outpacing Moores Law threefold. From an initial cost of $3.7 billion, it dropped to $10 million in 2006, and to $1,500 in 2015.

Today, the cost of genome sequencing has dropped below $600, and according to Illumina, the worlds leading sequencing company, the process will soon cost about $100 and take about an hour to complete.

This represents one of the most powerful and transformative technology revolutions in healthcare. When we understand your genome, well be able to understand how to optimize you.

In addition to reading the human genome, scientists can now edit a genome using a naturally occurring biological system discovered in 1987 called CRISPR/Cas9.

Short forClusteredRegularlyInterspacedShortPalindromicRepeats andCRISPR-associated protein9, the editing system was adapted from a naturally-occurring defense system found in bacteria.

Heres how it works. The bacteria capture snippets of DNA from invading viruses (or bacteriophage) and use them to create DNA segments known as CRISPR arrays. The CRISPR arrays allow the bacteria to remember the viruses (or closely related ones), and defend against future invasions. If the viruses attack again, the bacteria produce RNA segments from the CRISPR arrays to target the viruses DNA. The bacteria then use Cas9 to cut the DNA apart, which disables the virus.

Most importantly, CRISPR is cheap, quick, easy to use, and more accurate than all previous gene editing methods. As a result, CRISPR/Cas9 has swept through labs around the world asthe way to edit a genome. A short search in the literature will show an exponential rise in the number of CRISPR-related publications and patents.

Early results are impressive. Researchers have used CRISPR to genetically engineer cocaine resistance into mice, reverse the gene defect causing Duchenne muscular dystrophy (DMD) in dogs, and reduce genetic deafness in mice.

Already this year, CRISPR-edited immune cells have been shown to successfully kill cancer cells in human patients. Researchers have discovered ways to activate CRISPR with light and use the gene-editing technology to better understand Alzheimers disease progression.

With great power comes great responsibility, and the opportunity for moral and ethical dilemmas. In 2015, Chinese scientists sparked global controversy when they first edited human embryo cells in the lab with the goal of modifying genes that would make the child resistant to smallpox, HIV, and cholera. Three years later, in November 2018, researcher He Jiankui informed the world that the first set of CRISPR-engineered female twins had been delivered.

To accomplish his goal, Jiankui deleted a region of a receptor on the surface of white blood cells known as CCR5, introducing a rare, natural genetic variation that makes it more difficult for HIV to infect its favorite target, white blood cells. Because Jiankui forged ethical review documents and misled doctors in the process, he was sentenced to three years in prison and fined $429,000 last December.

Coupled with significant ethical conversations necessary for progress, CRISPR will soon provide us the tools to eliminate diseases, create hardier offspring, produce new environmentally resistant crops, and even wipe out pathogens.

Over the arc of your life, the cells in your body divide until they reach what is known as the Hayflick limit, or the number of times a normal human cell population will divide before cell division stops, which is typically about 50 divisions.

What normally follows next is programmed cell death or destruction by the immune system. A very small fraction of cells, however, become senescent cells and evade this fate to linger indefinitely. These lingering cells secrete a potent mix of molecules that triggers chronic inflammation, damages the surrounding tissue structures, and changes the behavior of nearby cells for the worse. Senescent cells appear to be one of the root causes of aging, causing everything from fibrosis and blood vessel calcification to localized inflammatory conditions such as osteoarthritis to diminished lung function.

Fortunately, both the scientific and entrepreneurial communities have begun to work on senolytic therapies, moving the technology for selectively destroying senescent cells out of the laboratory and into a half-dozen startup companies.

Prominent companies in the field include the following:

Unity Biotechnology is developing senolytic medicines to selectively eliminate senescent cells with an initial focus on delivering localized therapy in osteoarthritis, ophthalmology, and pulmonary disease.

Oisin Biotechnologiesis pioneering a programmable gene therapy that can destroy cells based on their internal biochemistry.

SIWA Therapeuticsis working on an immunotherapy approach to the problem of senescent cells.

In recent years, researchers have identified or designed a handful of senolytic compounds that can curb aging by regulating senescent cells. Two of these drugs that have gained mainstay research traction are rapamycin and metformin.

(1) Rapamycin

Originally extracted from bacteria found on Easter Island, rapamycin acts on the m-TOR (mechanistic target of rapamycin) pathway to selectively block a key protein that facilitates cell division. Currently, rapamycin derivatives are widely used for immunosuppression in organ and bone marrow transplants. Research now suggests that use results in prolonged lifespan and enhanced cognitive and immune function.

PureTech Health subsidiary resTORbio (which went public in 2018) is working on a rapamycin-based drug intended to enhance immunity and reduce infection. Their clinical-stage RTB101 drug works by inhibiting part of the mTOR pathway.

Results of the drugs recent clinical trial include decreased incidence of infection, improved influenza vaccination response, and a 30.6 percent decrease in respiratory tract infection.

Impressive, to say the least.

(2) Metformin

Metformin is a widely-used generic drug for mitigating liver sugar production in Type 2 diabetes patients. Researchers have found that metformin also reduces oxidative stress and inflammation, which otherwise increase as we age. There is strong evidence that metformin can augment cellular regeneration and dramatically mitigate cellular senescence by reducing both oxidative stress and inflammation.

Over 100 studies registered on ClinicalTrials.gov are currently following up on strong evidence of metformins protective effect against cancer.

(3) Nutraceuticals and NAD+

Beyond cellular senescence, certain critical nutrients and proteins tend to decline as a function of age. Nutraceuticals combat aging by supplementing and replenishing these declining nutrient levels.

NAD+ exists in every cell, participating in every process from DNA repair to creating the energy vital for cellular processes. Its been shown that NAD+ levels decline as we age.

The Elysium Health Basis supplement aims to elevate NAD+ levels in the body to extend ones lifespan. Elysiums first clinical study reports that Basis increases NAD+ levels consistently by a sustained 40 percent.

These are just a taste of the tremendous momentum that longevity and aging technology has right now. As artificial intelligence and quantum computing transform how we decode our DNA and how we discover drugs, genetics and pharmaceuticals will become truly personalized.

The next article in this series will demonstrate how artificial intelligence is converging with genetics and pharmaceuticals to transform how we approach longevity, aging, and vitality.

We are edging closer toward a dramatically extended healthspanwhere 100 is the new 60. What will you create, where will you explore, and how will you spend your time if you are able to add an additional 40 healthy years to your life?

(1) A360 Executive Mastermind:If youre an exponentially and abundance-minded entrepreneur who would like coaching directly from me, consider joining my Abundance 360 Mastermind, a highly selective community of 360 CEOs and entrepreneurs who I coach for 3 days every January in Beverly Hills, Ca. Through A360, I provide my members with context and clarity about how converging exponential technologies will transform every industry. Im committed to running A360 for the course of an ongoing 25-year journey as a countdown to the Singularity.

If youd like to learn more and consider joining our 2021 membership,apply here.

(2) Abundance-Digital Online Community: Ive also created a Digital/Online community of bold, abundance-minded entrepreneurs called Abundance-Digital. Abundance-Digital is Singularity Universitys onramp for exponential entrepreneursthose who want to get involved and play at a higher level.Click here to learn more.

(Both A360 and Abundance-Digital are part of Singularity Universityyour participation opens you to a global community.)

This article originally appeared ondiamandis.com. Read theoriginal article here.

Image Credit: Arek Socha from Pixabay

See the article here:
A Renaissance of Genomics and Drugs Is Extending Human ...

A gene called AHL15 (AT-hook motif nuclear-localized protein 15) promotes longevity in annual flowering plants, according to a new study published in the journal Nature Plants.

Left: wild-type Arabidopsis thaliana. Right: Arabidopsis thaliana with overexpressed AHL15. Image credit: Omid Karami.

Plants have growing points on their stems. These are groups of stem cells that can form new stems with leaves or flowers, said Professor Remko Offringa from the Institute of Biology Leiden at Leiden University, the Netherlands, and his colleagues.

In perennial plants, a number of those growing points remain vegetative, so that after flowering the plant can continue to grow in the next season. In annual plants, this does not happen and the plant dies.

We discovered a gene that determines whether growing points of a plant will remain vegetative after flowering.

For the study, Professor Offringa and co-authors used Arabidopsis thaliana, a rapidly growing flowering plant native to Europe, Asia and northern parts of Africa.

We overexpressed the AHL15 gene in Arabidopsis so that it is much more active than normal, they explained.

As with perennial plants, in the modified Arabidopsis plants some growing points remain in the vegetative phase.

The plants continue to grow after flowering and can blossom several times.

When the researchers disabled the AHL15 gene, they noticed that the plants had a shorter lifespan.

The discovery of the gene contributes to fundamental knowledge about plant life history and aging, Professor Offringa said.

The gene may also provide answers to the question of why during evolution certain species have become annuals and others have become perennial.

Many food crops, like rice and wheat, are annuals. Keeping some growing points vegetative in such a crop would allow the plants to continue to grow after harvesting. This may allow for several harvests from the same crop and thus to increase the yield per plant.

Farmers also have to plough less often when they grow plants that bloom more often. As a result, the soil biome will remain intact, which fits well with sustainable production in agriculture.

_____

O. Karami et al. A suppressor of axillary meristem maturation promotes longevity in flowering plants. Nat. Plants, published online April 13, 2020; doi: 10.1038/s41477-020-0637-z

Read the original:
Biologists Identify Longevity Gene in Flowering Plants ...

Maintaining a healthy lifestyle, including a well-rounded diet is crucial to prolonging your lifespan.

You could also boost your lifespan by doing regular exercise. Its the miracle cure weve all been waiting for, according to the NHS.

Making some small diet or lifestyle changes could help to increase your life expectancy and avoid an early death.

Drinking green tea is one of the best ways to lower your risk of a premature death, it's been revealed.

READ MORE: How to live longer - including more of this food in your diet may help

"We know there are no guarantees. But genetics account for just 25 percent of a persons longevity. The rest is up to you," said AARP.

"With this collection of some of the most important longevity findings, youll have the road map you need to get to 80, 90, 100 or beyond.

"If coffees not your thing, green tea also has proven longevity cred, likely because it contains powerful antioxidants known as catechins that may help combat diabetes and heart disease.

"In a large study of more than 40,000 Japanese men and women, drinking five or more cups of green tea a day was associated with a 12 percent decrease in mortality among men and a 23 percent decrease among women."

Meanwhile, you could also lower your risk of early death by regularly eating ginger, it's been revealed.

Ginger has been claimed to reduce inflammation in the colon, which has been linked with bowel cancer.

Dried spices provide the highest concentration of antioxidants, whereas freezing them preserves the antioxidants in fresh spices.

Everyone should liberally add a variety of spices to their meals, nutritionists have urged.

Read more:
How to live longer - the best morning tea to prevent an early death and avoid diabetes - Express

Ongoing research into why some people outlive others often confirms what intuition tells us - the importance of eating a nutritious diet, for example. Occasionally, however, research uncovers surprising links and a new study falls into that category. Research published in the International Journal of Environmental Research and Public Health sheds some light on the impact where you live has on your lifespan.

The research suggests that people who live in highly walkable, mixed-age communities may be more likely to live to their 100th birthday.

They also found socioeconomic status to be correlated, and an additional analysis showed that geographic clusters where the probability of reaching centenarian age is high are located in urban areas and smaller towns with higher socioeconomic status.

"Our study adds to the growing body of evidence that social and environmental factors contribute significantly to longevity, said study author Rajan Bhardwaj, a second-year WSU medical student who took an interest in the topic after serving as a home care aide to his aging grandfather.

Commenting on their findings, Ofer Amram, the study's senior author and an assistant professor who runs WSU's Community Health and Spatial Epidemiology (CHaSE) lab, said: "We know from previous research that you can modify, through behaviour, your susceptibility to different diseases based on your genetics."

READ MORE:How to live longer: The diet shown to reduce risk of early death by 18 percent - key foods

Another way to put it, when you live in an environment that supports healthy ageing, this likely impacts your ability to successfully beat your genetic odds through lifestyle changes.

However, there was a gap in knowledge as to the exact environmental and social factors that make for an environment that best supports living to centenarian age, which this study helped to address.

In collaboration with co-authors Solmaz Amiri and Dedra Buchwald, Bhardwaj and Amram looked at state-provided data about the deaths of nearly 145,000 Washingtonians who died at age 75 or older between 2011 and 2015.

The data included information on each person's age and place of residence at the time of death, as well as their sex, race, education level and marital status.

DON'T MISSHigh blood pressure - the five exercises you can do at home to prevent hypertension[TIPS]Dementia warning - one drink you should avoid if you want to prevent the condition[TIPS]Best supplements for the heart - the 3p a day capsules to lower your risk of heart attacks[TIPS]

Based on where the person lived, the researchers used data from the American Community Survey, Environmental Protection Agency, and other sources to assign a value or score to different environmental variables for their neighbourhood.

The variables they looked at included poverty level, access to transit and primary care, walkability, percentage of working age population, rural-urban status, air pollution, and green space exposure.

Subsequently, they conducted a survival analysis to determine which neighbourhood and demographic factors were tied to a lower probability of dying before centenarian age.

They found that neighbourhood walkability, higher socioeconomic status, and a high percentage of working age population (a measure of age diversity) were positively correlated with reaching centenarian status.

"These findings indicate that mixed-age communities are very beneficial for everyone involved," said Bhardwaj.

She added: "They also support the big push in growing urban centres toward making streets more walkable, which makes exercise more accessible to older adults and makes it easier for them to access medical care and grocery stores."

Amram added that neighbourhoods that offer more age diversity tend to be in urban areas, where older adults are likely to experience less isolation and more community support.

Finally, the researchers wanted to see in which areas of the state people had a higher probability of reaching centenarian age. For each neighbourhood, they calculated the years of potential life lost, or the average number of years deceased individuals would have had to continue living to reach age 100.

Neighbourhoods with lower values for years of potential life lost were considered to have a higher likelihood of reaching centenarian age, and vice versa.

When they mapped the years of potential life lost for all neighbourhoods across the state, they saw clusters with high likelihood of living to centenarian age in higher socioeconomic areas in urban centres and small towns.

While the researchers do not directly reference it in this study, happiness may also be a contributing factor.

Extensive evidence shows happiness brings innumerable benefits to longevity.

It is strongly associated with healthier eating habits and living with less stress, both of which are integral to a long life.

More:
How to live longer: Want to live to see 100? Buy a house in this area says new study - Express

The research report on Genomic Biomarker market, covering the COVID-19 impact, provides a comparative analysis of the historical data with the current market scenario to unveil the growth projections for the industry over the analysis period. As per the study, the market is expected to garner substantial returns and showcase a healthy growth rate throughout the forecast duration.

The market analysis boasts of a competitive market intelligence with respect to the major industry trends, sales volume, market size, growth prospects, and revenue estimates. Moreover, information pertaining to the various industry segmentations covers a large portion of the research. The study further extends through an impartial assessment of the key players in the industry.

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/11554

A gist of the regional analysis of the Genomic Biomarker market:

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/11554

Other inferences from the Genomic Biomarker market:

Research Methodology:

The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provides estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. Besides, the research methodology we follow is a systematic approach to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.

Reasons for buying this report:

The key questions answered in this report:

Significant Point Mentioned in theResearch report:

Major highlights of the Table of Contentsof the Genomic Biomarker market Size study:

Request Customization on This Report @ https://www.cuereport.com/request-for-customization/11554

Read more:
Genomic Biomarker Market Report, History and Forecast 2015-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application - CueReport

Zinc Market report is to provide accurate and strategic analysis of the Profile Projectors industry. The report closely examines each segment and its sub-segment futures before looking at the 360-degree view of the market mentioned above. Market forecasts will provide deep insight into industry parameters by accessing growth, consumption, upcoming market trends and various price fluctuations.

Zinc Market competition by top manufacturers as follow: , Korea Zinc Group, Nyrstar, Hindustan, Glencore Xstrata, Nexa Resources, Boliden, Shaanxi Nonferrous Metals, Teck, China Minmetals Corp, Noranda Income Fund, Rotometals, Minera Shouxin Peru, Compania Minera Milpo, Zincore Metals, Deutenberg, HATTLER & Sohn GmbH, U.S. Zinc, Ney Metals?Alloys, Chelyabinsk Electrolytic Zinc Plant, EKMEKCIOGULLARI, Accurate Perforating, AirMetals Inc, Clark Perforating, Fairview Architectural, RotoMetals, Umicore Technical Materials, Aldon Corporation, Eljen Technology, All-Chemie, Rheinzink

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/77967

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

Global Zinc Market research reports growth rates and market value based on market dynamics, growth factors. Complete knowledge is based on the latest innovations in the industry, opportunities and trends. In addition to SWOT analysis by key suppliers, the report contains a comprehensive market analysis and major players landscape.The Type Coverage in the Market are: Pure ZincZinc AlloyOthers

Market Segment by Applications, covers:ShipCarBridgeOther

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

To get this report at a profitable rate.: https://reportsinsights.com/discount/77967

Important Features of the report:

Reasons for buying this report:

Access full Report Description, TOC, Table of Figure, Chart, [emailprotected] https://reportsinsights.com/industry-forecast/Zinc-Market-77967About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Originally posted here:
Global Impact of Covid-19 on Zinc Market to Witness Promising Growth Opportunities During 20202026 with Top Leading Players Hindustan, Glencore...

The ' Genomic Biomarker market' study now available with Market Study Report, LLC, delivers a concise outlook of the powerful trends driving market growth. This report also includes valuable information pertaining to market share, market size, revenue forecasts, regional landscape and SWOT analysis of the industry. The report further elucidates the competitive backdrop of key players in the market as well as their product portfolio and business strategies.

The Genomic Biomarker market report offers a thorough evaluation of this industry space and comprises of insights pertaining to the market tendencies including current remuneration, revenue predictions, market size and market valuation during the analysis timeframe.

A summary of the performance analysis of the Genomic Biomarker market is stated in the document. The study also provides with information concerning the key industry trends and the estimated growth rate of the market. The report delivers details regarding the growth opportunities and the inhibiting factors for this business vertical.

Request a sample Report of Genomic Biomarker Market at:https://www.marketstudyreport.com/request-a-sample/2493307

This study specially analyses the impact of Covid-19 outbreak on the Genomic Biomarker , covering the supply chain analysis, impact assessment to the Genomic Biomarker market size growth rate in several scenarios, and the measures to be undertaken by Genomic Biomarker companies in response to the COVID-19 epidemic.

Key aspects highlighted in the Genomic Biomarker market report:

As per the regional scope of the Genomic Biomarker market:

Genomic Biomarker Market Segmentation:

An overview of the details provided in the Genomic Biomarker market report:

Ask for Discount on Genomic Biomarker Market Report at:https://www.marketstudyreport.com/check-for-discount/2493307

A summary of the Genomic Biomarker market as perthe product type and application scope:

Product landscape:

Product types:

Oncology, Cardiology, Neurology and Nephrology

Key parameters included in the report:

Application Spectrum:

Application segmentation:

Hospitals and Diagnostic and research laboratories

Specifics offered in report:

Other data cited in the report:

Additional information concerning the competitive terrain of the Genomic Biomarker market:

Vendor base of Genomic Biomarker market:

The major players covered in Genomic Biomarker are:, Bio-Rad, Almac, Thermo Fisher Scientific, Beckman Coulter, Epigenomics, Myriad Genetics, Human Longevity, QIAGEN, Roche, Pfizer, Agilent, ValiRx, Illumina, Empire Genomics, Personalis and Eagle Genomics

Major aspects as per the report:

Research objectives:

Report Answers Following Questions:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-genomic-biomarker-market-2020-by-company-regions-type-and-application-forecast-to-2025

Related Reports:

1. Global Polycystic Ovary Syndrome Market 2020 by Company, Regions, Type and Application, Forecast to 2025Read More: https://www.marketstudyreport.com/reports/global-polycystic-ovary-syndrome-market-2020-by-company-regions-type-and-application-forecast-to-2025

2. Global Prostate Cancer Diagnosis and Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025Read More: https://www.marketstudyreport.com/reports/global-prostate-cancer-diagnosis-and-treatment-market-2020-by-company-regions-type-and-application-forecast-to-2025

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Visit link:
Genomic Biomarker Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2025...

Precision Medicine SoftwareMarket 2020: Inclusive Insight

Los Angeles, United States,June 2020:The report titled Global Precision Medicine Software Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Precision Medicine Software market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Precision Medicine Software market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Precision Medicine Software market is carefully analyzed and researched about by the market analysts.

Precision Medicine Software Market competition by top manufacturers/ Key player Profiled: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/867663

Global Precision Medicine Software Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020- 2025. According to the latest report added to the online repository of Alexareports the Precision Medicine Software market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Based on region, the globalPrecision Medicine Software market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Precision Medicine Software Market Segment by Type covers: Cloud-based, On-premise

Precision Medicine Software Market Segment by Industry: Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Others

After reading the Precision Medicine Software market report, readers get insight into:

*Major drivers and restraining factors, opportunities and challenges, and the competitive landscape*New, promising avenues in key regions*New revenue streams for all players in emerging markets*Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions*Demand and uptake patterns in key industries of the Precision Medicine Software market*New research and development projects in new technologies in key regional markets*Changing revenue share and size of key product segments during the forecast period*Technologies and business models with disruptive potential

Key questions answered in the report:

What will the market growth rate of Precision Medicine Software market?What are the key factors driving the global Precision Medicine Software market size?Who are the key manufacturers in Precision Medicine Software market space?What are the market opportunities, market risk and market overview of the Precision Medicine Softwaremarket?What are sales, revenue, and price analysis of top manufacturers of Precision Medicine Software market?Who are the distributors, traders, and dealers of Precision Medicine Software market?What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Softwareindustries?What are sales, revenue, and price analysis by types and applications of Precision Medicine Softwaremarket?What are sales, revenue, and price analysis by regions of Precision Medicine Software industries?

Get a discount on this report now at https://www.alexareports.com/check-discount/867663

Table of ContentsSection 1 Precision Medicine Software Product DefinitionSection 2 Global Precision Medicine Software Market Manufacturer Share and Market Overview2.1 Global Manufacturer Precision Medicine Software Shipments2.2 Global Manufacturer Precision Medicine Software Business Revenue2.3 Global Precision Medicine Software Market Overview2.4 COVID-19 Impact on Precision Medicine Software IndustrySection 3 Manufacturer Precision Medicine Software Business Introduction3.1 Syapse Precision Medicine Software Business Introduction3.1.1 Syapse Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.1.2 Syapse Precision Medicine Software Business Distribution by Region3.1.3 Syapse Interview Record3.1.4 Syapse Precision Medicine Software Business Profile3.1.5 Syapse Precision Medicine Software Product Specification3.2 Allscripts Precision Medicine Software Business Introduction3.2.1 Allscripts Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.2.2 Allscripts Precision Medicine Software Business Distribution by Region3.2.3 Interview Record3.2.4 Allscripts Precision Medicine Software Business Overview3.2.5 Allscripts Precision Medicine Software Product Specification3.3 Qiagen Precision Medicine Software Business Introduction3.3.1 Qiagen Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Qiagen Precision Medicine Software Business Distribution by Region3.3.3 Interview Record3.3.4 Qiagen Precision Medicine Software Business Overview3.3.5 Qiagen Precision Medicine Software Product Specification3.4 Roper Technologies Precision Medicine Software Business Introduction3.5 Fabric Genomics Precision Medicine Software Business Introduction3.6 Foundation Medicine Precision Medicine Software Business IntroductionSection 4 Global Precision Medicine Software Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Precision Medicine Software Market Size and Price Analysis 2014-20194.1.2 Canada Precision Medicine Software Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Precision Medicine Software Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Precision Medicine Software Market Size and Price Analysis 2014-20194.3.2 Japan Precision Medicine Software Market Size and Price Analysis 2014-20194.3.3 India Precision Medicine Software Market Size and Price Analysis 2014-20194.3.4 Korea Precision Medicine Software Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Precision Medicine Software Market Size and Price Analysis 2014-20194.4.2 UK Precision Medicine Software Market Size and Price Analysis 2014-20194.4.3 France Precision Medicine Software Market Size and Price Analysis 2014-20194.4.4 Italy Precision Medicine Software Market Size and Price Analysis 2014-20194.4.5 Europe Precision Medicine Software Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Precision Medicine Software Market Size and Price Analysis 2014-20194.5.2 Africa Precision Medicine Software Market Size and Price Analysis 2014-20194.5.3 GCC Precision Medicine Software Market Size and Price Analysis 2014-20194.6 Global Precision Medicine Software Market Segmentation (Region Level) Analysis 2014-20194.7 Global Precision Medicine Software Market Segmentation (Region Level) AnalysisSection 5 Global Precision Medicine Software Market Segmentation (Product Type Level)5.1 Global Precision Medicine Software Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Precision Medicine Software Product Type Price 2014-20195.3 Global Precision Medicine Software Market Segmentation (Product Type Level) AnalysisSection 6 Global Precision Medicine Software Market Segmentation (Industry Level)6.1 Global Precision Medicine Software Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Precision Medicine Software Market Segmentation (Industry Level) AnalysisSection 7 Global Precision Medicine Software Market Segmentation (Channel Level)7.1 Global Precision Medicine Software Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Precision Medicine Software Market Segmentation (Channel Level) AnalysisSection 8 Precision Medicine Software Market Forecast 2019-20248.1 Precision Medicine Software Segmentation Market Forecast (Region Level)8.2 Precision Medicine Software Segmentation Market Forecast (Product Type Level)8.3 Precision Medicine Software Segmentation Market Forecast (Industry Level)8.4 Precision Medicine Software Segmentation Market Forecast (Channel Level)Section 9 Precision Medicine Software Segmentation Product Type9.1 Cloud-based Product Introduction9.2 On-premise Product IntroductionSection 10 Precision Medicine Software Segmentation Industry10.1 Healthcare Providers Clients10.2 Pharmaceutical and Biotechnology Companies Clients10.3 Research Centers and Government Institutes Clients10.4 Others ClientsSection 11 Precision Medicine Software Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/867663

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Read this article:
(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,...

Precision Medicine Software Market report focused on the comprehensive analysis of current and future prospects of the Precision Medicine Software industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Precision Medicine Software market has been done in order to calculate the growth rates for each segment and sub-segments.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=79150

Top Key Vendors of this Market are:

Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Lifeomic Health.

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Precision Medicine Software market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Precision Medicine Software markets trajectory between forecast periods.

The report provides insights on the following pointers:

Market Penetration:Comprehensive information on the product portfolios of the top players in the Precision Medicine Software market.

Product Development/Innovation:Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development:Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments in the Precision Medicine Software market.

Hurry Up! Get Upto 25% Discount on this Report @:

https://www.a2zmarketresearch.com/discount?reportId=79150

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Precision Medicine Software market. It focuses on the major points, which are necessary to make positive impacts on the market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

Table of Contents

Global Precision Medicine Software Market Research Report 2020 2026

Chapter 1 Precision Medicine Software Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Precision Medicine Software Market Forecast

For more Information, Inquire @:

https://www.a2zmarketresearch.com/enquiry?reportId=79150

If you have any special requirements, please let us know and we will offer you the report as you want.

Read the original here:
Precision Medicine Software Market Breaking New Grounds and Touch new Level in Upcoming Year by Syapse, Allscripts, Qiagen, Roper Technologies, Fabric...

Alyssa Powell/Business Insider

In order to figure out a maintenance schedule that works for you, identifying which category your hair falls under straight, wavy, curly, or extra curly (coily) is a good place to start. However, according to Hannah Reid, a stylist at Nine Zero One Salon and a certified trichologist technician, there are many factors that determine someone's hair type. These include hair texture, structure, porosity, and density.

Your hair texture refers to your natural curl pattern. It's established by your genetics, but can be altered through chemical processing and environmental factors. Since certain textures of hair respond differently to certain types of shampoos, it's good to identify your hair type first and foremost.

It's easy to determine what your natural hair texture is. All you have to do is shower and let your hair dry without any product in it.

"If it dries without a bend or S shape then your hair is considered straight (type 1)," explains Reid. "If your hair dries with a slight bend or S shape then your hair is considered wavy (type 2). If your hair dries with what looks like a loop pattern or defined curl, your hair is curly (type 3). If you have extra curly or coily texture (type 4) your hair will have spirals or a zig zag pattern."

Straight hair tends to require more frequent washing and lighter-weight formulas, while curlier hair can usually handle denser, more moisturizing shampoos and longer times between washes.

Your hair structure refers to the diameter or thickness of one individual strand and is categorized as either fine, medium, or thick (coarse). In order to determine your hair structure, Reid suggests plucking a single strand of hair from your head and laying it next to a piece of sewing thread.

"If your hair strand appears to be thinner than the thread, you have fine hair," Reid tells INSIDER. "If it appears thicker than the thread it is considered thick (coarse). Anything in between is medium."

Fine hair generally requires more frequent washing than coarse hair.

People often confuse hair structure for hair density, but they are not one and the same. While hair structure is determined by one single strand, your hair density refers to how much hair is on your head, per square inch.

The average person has roughly 2,200 strands of hair per square inch, but to count out that many pieces per square inch would be tedious. Instead, in order to determine your hair's density, Reid suggests putting your hair to the ponytail test.

"Put your hair in a ponytail then measure the circumference of your ponytail," instructs Reid. "If it measures less than 2 inches then it has low density. If it measures 2 to 3 inches then it's medium, 3 to 4 inches it's high density."

Low-density hair generally requires more frequent washings.

Like a sponge, your hair is porous in that it absorbs and retains moisture and oils. The question is, how well does it do this?

If your hair is highly porous, meaning the cuticle layer has gaps and tears in it, it absorbs moisture too quickly and releases moisture at a very high rate, says Reid. "This makes the hair dry, brittle and easily prone to breakage." But if your hair has low porosity, the cuticle layer doesn't open enough and barely absorbs any moisture at all. This can lead to product buildup, "because it is not actually penetrating into the hair shaft."

Generally, low-porosity hair will need to be washed more often due to product buildup, while high-porosity hair can go longer between washes.

Hair with medium porosity in which case the cuticle doesn't open too much or too little is the easiest to manage, Reid says. It allows in and retains just the right amount of moisture to make styling and coloring a breeze, and generally looks the healthiest, too.

So, how can you determine your hair's porosity? The easiest way is to fill a bowl of water and place one strand of hair in it, Reid says. "If it sinks to the bottom that means you have high porosity. If it floats below the surface, but doesn't touch the bottom, you have normal porosity. If it floats at the top of the water, you have low porosity."

Link:
How often should you wash your hair? We asked a trichologist to answer - Insider - INSIDER

Kyle Caires takes a selfie with prized wagyu cattle. Photos courtesy of Kyle Caires

Animal scientist Kyle Caires and a research team have found a way to nearly double pregnancy rates in wagyu, a Japanese breed of cattle that typically has low rates of reproduction but is prized for its meat.

By using technologies, such as artificial insemination, and pairing them with nutrition, management techniques and healthy and controlled environments, ranchers can improve their cattles reproductivity for less costs.

And meat lovers and chefs can have more access to high-quality beef.

Outcomes are much better when you work with Mother Nature, instead of against her, and the same is true when raising livestock, said Caires, the Maui extension agent for the University of Hawaii-Manoa College of Tropical Agriculture and Human Resources. Therefore, choosing genetics with production levels calving ease, growth rate, milk production to fit a ranchs forage resources, rainfall level and availability of labor, is a great approach for all ranchers in Hawaii.

Caires, who works in the Department of Human Nutrition, Food and Animal Sciences, recently published his research on how to improve the reproductive rates of the Japanese Black. He also spent the last six weeks setting up programs for ranchers and beef producers across Maui County.

Kyle Caires, Maui extension agent for the University of Hawaii-Manoa College of Tropical Agriculture and Human Resources, analyzes cattle embryo samples.

CTAHR programs include educational programs and outreach assistance to ranchers that want to consider estrus synchronization, artificial insemination, semen testing and pregnancy checking. He said that embryo transfers will be offered in the near future.

Excellent pregnancy rates are achieved with integrated approaches that combine genetic improvement strategies with good management practices on a case-by-case basis, not a one-size-fits-all approach, he said.

These safe procedures are no different than what would happen naturally in cattle reproduction, he said. For example, for ranchers breeding first-calf heifers, artificial insemination could help improve productivity because semen from bulls are proven to produce low-weight births, which makes the birthing process easier for first-time mothers, which in turn is better for the cows longevity and health.

Likewise, the semen used in artificial insemination protocols also must pass biosecurity measures to eliminate disease transmission, an added bonus, he said.

In collaboration with researchers from Washington state and Brazil, the article titled, The outcome and economic viability of production using IVF and SOV techniques in the Wagyu breed of cattle, was published May 1 in Veterinary Sciences.

The methods showed a 70 percent decrease in cost compared to typical genetic improvement strategies, Caires said.

Seven ranches on Maui, as well as several on Molokai, Oahu, Kauai and Hawaii island, are utilizing wagyu genetics already. However, due to their lower productivity, Caires said that most ranches maintain wagyu cross-breeds, not pure-breds.

Successful conception rates are between 75 and 80 percent following a single round of artificial insemination, he said, which is much greater than the national average of 60 percent for cows.

Other tips to improve beef reproduction include good nutrition, lowering stress, routine vaccinations, pasture and grazing management, as well as scoping out cows with genetic potential.

All the little things add up to a strong foundation that pays big dividends to set ranchers up for success when using technologies, like artificial insemination, where they can also utilize elite genetics from across the country at a fraction of the cost, he said. In order for AI to be consistently successful at the ranch, reproductive management protocols are used to help ranchers better time the delivery of semen in to match the ovulation event in the cows.

Moving forward, Caires plans to continue his applied research in order to improve genetics, reproductive efficiency and overall productivity for local farmers.

The main goal of our research is to help Hawaiis ranchers remain competitive in a dynamic, ever-changing global beef industry, he said.

To review the results of the study, visit mdpi.com/2306-7381/7/2/58/htm. For information about CTAHR programs on Maui, visit ctahr.hawaii.edu/Maui/pages/Programs.aspx.

* Dakota Grossman can be reached at dgrossman@mauinews.com.

Today's breaking news and more in your inbox

View post:
Where's the wagyu? | News, Sports, Jobs - Maui News

Peggy Cobb is one of the few individuals around the world who have experienced both the Spanish flu outbreak of 1918-19 and todays COVID-19 pandemic.

The 105-year-old Sandy Springs resident was only a toddler during the earlier pandemic, but she has vivid memories of it.

Everyones (homes) were in lockdown, said Cobb, who grew up in southern Minnesota. They called it quarantine back then. I remember my dad (Frederick Vanstrom) was called a couple of blocks (away) to help a friend whose wife had the Spanish flu, and she actually died. Dad was not allowed to come back to our house (temporarily), just like in here now. The (pandemics then and now) were an awful lot alike.

I was too young to remember anything (else) except we were in quarantine. I grew up in a family where we were so secure that somehow nobody ever worried about getting it.

Cobb, who has not contracted either virus, talked about that experience and more in an interview with the Neighbor before her 105th birthday party at the Hammond Glen Retirement Community where she lives.

Regarding todays outbreak, Hammond Glen, like some retirement homes, has not allowed visitors to come into the building to see residents such as friends or family members. But it has allowed its residents to go outside to see them. Cobb said living under those conditions has been a breeze.

Oh, listen. It hasnt been a bit difficult for me, she said. I am so interested in everything going on that, really, my life hasnt changed. I keep busy with all unfinished projects. I dont know what it would be like to be bored or anything, no. Im a compulsive writer also.

Cobb, a retired art teacher, lived in Terre Haute, Indiana, as an adult before moving to Hammond Glen in 2007. She and her husband, Jacob, were married for 59 years until his death in 2002, and shes has lived through 18 U.S. presidents.

During the Great Depression, her father owned a small bank that closed in 1929, so the family started farming to make a living. Longevity runs in the family for Cobb, one of six siblings, including five girls. Two of her sisters lived to be 104 and 105 and the other two died in their 90s, her son Bill said, adding its very cool to see his mother turn 105.

I wish I had her energy, her mind still being as sharp as it is, he said. I think its part of whats made her last this long. She just has an intense curiosity about the world. She has a saying thats on her refrigerator that says, Learn something new every day. Shes also one of these people that, no matter what happens, she always finds a way to make lemonade out of lemons. Those two things together, plus genetics.

Cobb has two sons, Bill and Pete, and two grandchildren. Her daughter, Katy, died in her 50s. Cobb said her positive attitude has helped her live over a century.

When we were growing up, we revered nature, that sort of thing, she said. I guess curiosity is one of the big words. (Regarding) the lockdown here, I could cope with that just fine. I just think one of the saddest things Ive seen living in this place is when you know somebody whos had an active mind and everything, and then you see the mind deteriorate. If its a physical thing taking it, they cant do anything about it. I think a lot of the people, they lose interest in everything.

Cobb also said everyone should share your ideas, one of many quotes or phrases she loves to cite.

She loves sayings, her son said. Her refrigerators full of them, and the last one she would share with (others) is: Stay flexible and youll never get bent out of shape. And one she got from her parents, that was, Furnish your mind well and you always have a comfortable place to live. Those are two of her favorites.

See the original post here:
Sandy Springs woman, 105, reflects on living through the Spanish flu and COVID-19 pandemics - MDJOnline.com

The Precision Medicine Software market report focuses on the COVID-19 Outbreak Impact analysis of key points influencing the growth of the market. The intelligence report prepared contains details on the leading players of the global market, along with various depending aspects related and associated with the market. Profile the Top Key Players, with sales, revenue and global market shares are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated.

The study encompasses profiles of major companies operating in the global Precision Medicine Software market.

Key players profiled in the report include:

SyapseAllscriptsQiagenRoper TechnologiesFabric GenomicsFoundation MedicineSophia GeneticsPierianDxHuman LongevityTranslational SoftwareGene42, IncLifeomic Health

***To know How COVID-19 Pandemic Will Impact This Market/Industry | Request a Sample copy of the Report: https://www.reportspedia.com/report/technology-and-media/global-precision-medicine-software-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/32812 #request_sample

The Precision Medicine Software market business development trends and selling channels square measure analyzed. This industry research report enriched on worldwide competition by topmost prime manufactures which providing information such as Company Profiles, Gross, Gross Margin, Capacity, Product Picture and Specification, Production, Price, Cost, Revenue and contact information.

Analysis of Global Precision Medicine Software Market: By Type

Cloud-basedOn-premise

Analysis of Global Precision Medicine Software Market: By Application

Healthcare ProvidersPharmaceutical and Biotechnology CompaniesResearch Centers and Government InstitutesOthers

Our exploration specialists acutely ascertain the significant aspects of the global Precision Medicine Software market report. It also provides an in-depth valuation in regards to the future advancements relying on the past data and present circumstance of market situation. In this report, we have investigated the principals, players in the market, geological regions, product type, and market end-client applications. The global Precision Medicine Software report comprises of primary and secondary data which is exemplified in the form of pie outlines, tables, analytical figures, and reference diagrams. The Precision Medicine Software report is presented in an efficient way that involves basic dialect, basic outline, agreements, and certain facts as per solace and comprehension.

>>> To get Exclusive Discount Inquiry Here @ https://www.reportspedia.com/report/technology-and-media/global-precision-medicine-software-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/32812 #inquiry_before_buying

Global Precision Medicine Software Market by Geography:

What You Can Expect From Our Report:

Each segment of the global Precision Medicine Software market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the market through leading segments. This research report categorizes the market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors, customers, research findings & conclusion, appendix & data source and Porters Five Forces Analysis.

A short outline of the pointers encompassed in the Precision Medicine Software market scope:

There are 10 Chapters to deeply display the Precision Medicine Software market:

Chapter 1, is executive summary of Precision Medicine Software Market;

Chapter 2, is definition and segment of Precision Medicine Software ;

Chapter 3, to show info and data comparison of Precision Medicine Software Players;

Chapter 4, to explain the industry chain of Precision Medicine Software ;

Chapter 5, to show comparison of regions and courtiers (or sub-regions);

Chapter 6, to show competition and trade situation of Precision Medicine Software Market;

Chapter 7, to show comparison of applications;

Chapter 8, to show comparison of types;

Chapter 9, to show investment of Precision Medicine Software Market;

Chapter 10, to forecast Precision Medicine Software, market in the next years;

Summary of Precision Medicine Software Market: Precision Medicine Software is a service that provides information to its subscribers. The subscribers can subscribe to magazines, daily papers, academic quarterlies, and/or online news.

View Report TOC In detail @ https://www.reportspedia.com/report/technology-and-media/global-precision-medicine-software-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/32812 #table_of_contents

Continue reading here:
Global Precision Medicine Software Market To Witness The Highest Growth Globally In Coming Years 2020-2026 - Cole of Duty

The cannabis market is boomingnot just across the United States, but all over the world. In domino fashion, stigmas are falling and people are embracing a new perspective on cannabis. Not long ago, the war on cannabis was in full throttle. Now, old-school growers and opportunistic entrepreneurs have stepped forward to claim a piece of the proverbial pie.

Its important to examine data for how states fare after launching a legalized cannabis market. Pre-existing cannabis markets, like in Colorado and California, will exhibit different trends over time than brand-new markets like Oklahoma. For instance, the Washington state market grew 100 percent from 2015 to 2016. The following year, the rate declined to about 33 percent. Going into 2018, the growth estimate was about 10 percent, according to Headset. Its easy to see the trend: an initial explosion cools down over time. Who is still standing once growth plateaus? Thats the important question.

Cannabis legalization presents a massive opportunity, so its no surprise big capital and investment is rolling in across borders and state lines. Multi-state operators (MSOs) are growing in size. Take Curaleaf, for example, which plans to operate seventy-one dispensaries in fifteen states by the end of 2020. This is a new kind of cannabis business. They scale by acquiring licenses and operators. Market share can be bought and sold like any other commodity.

When it comes to growing and feeding the plants, no two cultivators offer the same philosophy, feeding recipe, or training protocol.

Depending on where you are, different market forces will work for or against you. New states like Oklahoma have comparatively lax regulations that have inspired hobby growers and opportunists to stake a claim. Then there are states like Illinois, in which a publicly traded real estate firm is acquiring three of the seven total cultivation licenses.

In maturing markets, recent data show wholesale pricing for cannabis is increasing. Last year reversed a downward trend in pricing over the previous four years. But in any market, new or mature, overproduction and saturation can occur.

The days of easy sales at premium prices are getting farther away from us. So, how do growers face the changing tides and establish a sustainable cultivation business?

At one time, being a skilled grower was enough to command high prices and constant demand for product. Now, with increasing competition, MSOs, and price volatility, growers are wondering how to ensure their product sells and how to stabilize margins to ensure longevity for their business.

In general, indoor-grown product will command a higher price solely because of the cost of inputs and higher THC levels. But some outdoor growers can command top-shelf pricing for their flower. How do they do it?

Memorable branding

Beyond the commodity-versus-premium comparison lies another variable: branding. We wont name names, but crappy product can and does command a high price if its wrapped in premium branding and packaging. Its all about the first impression.

Good branding coupled with low-quality product may not prove successful over the long term, though. As customers mature in their preferences, they learn which brands offer the best value. If product smells good, tastes good, and feels good, it always will command a good price, special packaging or not. With so many choices on the shelf, why would a customer go back to the same over-priced brand when they can get a much better smoke from another?

Heres a tip: invest in a good designer or design agency to lead the branding process. Dont try to wing it yourself or hire someone from 99designs. Take the time to develop your brand positioning and messaging. Even if consumers love your product so much they dont care what the packaging looks like, the package needs to be memorable so theyll be able to find your product the next time they want to buy.

Your favorite brands, as simple as their marketing materials may seem, all have a very strong brand framework. Take the time and make the investment to create one of your own.

Science as art

Some cultivators are truly passionate about mastering the art and science of growing. Factors like aroma, flavor, and effects are achieved through breeding efforts in search of the perfect combination of genetic traits. When it comes to growing and feeding the plants, no two cultivators offer the same philosophy, feeding recipe, or training protocol. There are a million ways to create great weed.

As customers mature in their preferences, they learn which brands offer the best value.

The pursuit of next-level cannabis is responsible for decades of crossbreeding in Californias Emerald Trianglewhere cannabis breeding got its startand beyond. In fact, cannabis may be one of the most bred plants in the world.

The absence of standardized growing methods and consumers differing preferences for strains and effects provide growers huge opportunities to define their style and product offering among an ever-growing field of competitors.

Here are some ideas to get you thinking about how you might position yourself to stand out in the crowd:

Are your genetics unique? What is your best strain and what makes it so? (Run that full terpene analysis!)

Do you use full automation or give each plant your undivided attention?

Do you use customized formulas? Think schedule, feeding, topping or super-cropping, and curing methods.

Whats your personal story? You can build a powerful brand based on who you are, where you come from, and why you do what you do.

Unique partnerships

Another way to gain recognition and brand awareness in a competitive space is to leverage others networks. Together, two brands cast a bigger shadow than either does on its own.

Take for example the hip brand Space Coyote. The company infuses its joints with high-quality cold water hash from the respected Humboldt brand Nasha. Space Coyote was a startup in 2019, but its partnership with Nasha gave the company a bit of authority right from the start, which makes a big difference for a nascent brand.

Now, Space Coyote lends authority back to Nasha. As Space Coyotes pre-rolls grow in popularity, Nashas reputation increases as well. The partnership allows two complimentary brands to up each others games.

Think co-branding on packaging, or co-sponsor an event for the cannabis community or consumers. Cross-promote each other through social media, in email, and on websites. Good partnerships boost brand awareness.

Be sure to pick a trusted partner. Your reputation will depend on theirs. If they make a blunder and get bad press, your name is on the line, too.

Manage profit margins

However your pricing strategy may look, keeping a close eye on margins and profitability is crucial to sustained success. Large grows with hefty investment can afford to work with slim to no margins. For them, market share can be more important than raw profit.

Other businesses survive from harvest to harvest. Healthy margins are extremely important. Being able to reinvest in the business should be every growers goal.

Pay attention to margins ahead of when everyone else starts to squeeze. Increase prices, lower costs, or rely on an economy of scale, but stay one step ahead of the competition.

Increase efficiency

Efficiency comes in many forms: labor, cost of inputs, equipment choices, energy savings, even genetics. One grower made huge efficiency improvements by examining data about time and task management, environmental conditions, and plant batch analytics, then using the trends they noticed to modify their operations.

Hand-watering, for example, was incredibly expensive: Watering alone accounted for 30 percent of the cultivators labor costs. Initially, they implemented more efficient watering practices, but that made only a small difference in man-hours. After crunching more numbers, they invested in an auto-watering system. The investment paid for itself in two months.

The point is, there are efficiencies to be gained everywhere you look in your organization. Data can play into your competitive edge. This is especially true for those with multiple grow rooms or facilities.

Data is power

Software that collects and analyzes data in order to help businesses make informed decisions should be on everyones radar, as it can provide demonstrable competitive advantage. Most third-party software systems handle compliance by integrating with track-and-trace systems like Metrc or BioTrack. Cultivators probably also want built-in utilities for tracking employee productivity and providing performance analytics.

While all-in-one tools seem like a good idea, stacking purpose-built software can have a greater impact. Adding cultivation-focused software can address inefficiencies and improve production quality and yieldsespecially in the cannabis industry, where there are unique scenarios and data points many general-purpose software tools just dont address.

The more accurate and more comprehensive your data, the smarter your business decisions can be.

Ella Alpina is marketing manager at Trym, a farm management and compliance software company. Prior to Trym, she launched a licensed cannabis business in California and before that, founded and led a full-service marketing agency. She has worked in the cannabis space since 2014 and is passionate about the intersection of technology and cannabis.

Read the rest here:
The cannabis market is boomingnot just across the United States, but all over the world. In domino fashion, s - mg Cannabis Retailer

As the saying goes, Knowledge is power. For you to make positive changes that will enable you tolive a healthier life, you need to learn and understand more about yourself. Technology has now made it easier for us to make informed choices.

There is a lot of data that has been collected and collated that reveals the truth to us. Using data analytics, we can be able to tell: how what we eat affects our longevity, how our surrounding affects our health, and what lifestyle changes we can make to boost our immunity from diseases.

In this article, we discuss how smart technology can help us live a healthier life.

Data Science

We can shrink the number of deaths caused by non-communicable diseases. This can be achieved by leveraging the power of data.

Data analytics can help us focus more on preventive measures rather than treating illnesses. With enough data on these diseases available, governments are able to formulate policies that will help prevent them from becoming prevalent.

Health Applications

To help change the focus from curative measures to preventive measures, individuals need to take more responsibility. More often, individuals are aware of what is beneficial to them; however, they have difficulty in altering their daily routines.

Smart technology can help you change your daily routine. There are more than 100,000 health applications available in the market. You can download one to your mobile phone that can guide you through.

For instance, you can get a mobile phone app that helps you to measure your physical activity. You can also get apps that will provide you with health-related advice.

Wearable Technology

Wearable technology has also contributed significantly in improving our healthcare systems. Combined with data analysis, this technology is already changing lives.

With wearable devices such as smartwatches, smart bracelets, among others, we can keep track of our health. The devices will alert you about where you are going and encourage you to be less sedentary.

Wearable technologies hold up a mirror to your lifestyle so that it becomes easier for you to initiate positive behavioral changes.

Smart Homes

With the advent of wireless technology, smart homes are quickly becoming a reality. Science has provided evidence that our homes and buildings are often unhealthy.

Some of the things that make our homes unhealthy include poor air quality and lighting. Thanks to smart home technology, you can now accurately measure all the essential variables.

Innovations in smart home technology enable us to practically solve these problems hence, allowing us to build homes that are healthy and sustainable.

Precision Medicine

Precision medicine uses your DNA to create individualized medical treatments. With precision medicine, it is possible to treat diseases that were previously costly and hard to manage. Examples of such diseases include cancer, neurological disorders, and other rare genetic conditions.

With precision medicine, novel treatments are created using genetics and other individual variables. This technology will significantly help us live healthier lives. For those individuals that are already living with conditions such as diabetes, cancer, among others, this technology will help them manage the conditions better.

Read more from the original source:
How Smart Technology Can Lead To Healthier Lives - HealthTechZone

Express News Service

With tennis in 2020 almost lost due to COVID-19 & Olympics postponed, Leander Paes says he will reevaluate his career once everything is back to normal. In a chat with Indraneel Das, he gives a peek into life after retirement and challenges to stay fit...

Tennis legend Leander Paes is one of those few mortals on this planet who finds joy in everything. Tennis is definitely an inseparable part of him, but the lockdown has given him ample time to reinvent himself, pursue his passion that couldnt be done while on tours and focus on life after tennis. In a freewheeling interview, he reveals his future and recollects those moments that make him the Leander Paes. Wait he is not done with Olympics (that has been postponed to 2021), not as yet. Excerpts...

You have been associated with sports for over 30 years. Are you redefining the meaning of longevity?

I am blessed to have some great friendships in my career. With someone like Martina Hingis, Martina Navratilova, Roger Federer, Andre Agassi in my sport alone. In other sports, you look at Sachin Tendulkar, Bhaichung Bhutia, Vishi (Viswanathan) Anand to name a few, they have had very long careers. I have tried to learn from my peers and friends about that extra one per cent of diet, fitness, mental happiness, recovery and how to keep reinventing myself. I have been very blessed to have such a long career partly thanks to genetics from my parents but most importantly, the hard work that I have put in for over 30 years.

When you talk about reinventing yourself, do you mean motivating yourself all over again or setting new goals and targets?

All of the above. If you look at physical fitness. I remember my 33rd year, I felt I was quite exhausted at that time. I felt exhausted, thanks to the travel and the hours of training in the gym, on the tennis court; the long days that it takes to be a Grand Slam champion. I came back to my team. To my father and my fitness coach and my dietician and my mental trainer.

I reinvented my training system and then when I was 43, I had to reinvent again. Now one month shy of my 47th birthday, I have had to reinvent again with this lockdown period. So I think that its very important as a student of my craft or as a student of life to keep learning new things. I think that is one aspect of all the great champions in the world that I know. I have seen that they all reinvent themselves in all aspects of their lives.

Mentally, have you been very tough?

Yes, I think there are three different things. One is emotional fitness, two, physical fitness and three, there is tennis fitness the technical side, strategy; especially during times like these, emotional fitness and physical fitness are important.

Can you put in perspective postponement of Olympics vis-a-vis your career? You had said this would be your last Olympics.

This was my last season and it started off brilliantly at the Australian Open. I got a grand farewell there. Pune (Open) was a nice run. Bangalore was nice. Dubai, I got a wonderful farewell, Bangalore too. But then after the Davis Cup in Croatia, everything came to a standstill. We were fairly lucky in Croatia.

After we finished on Sunday and travelled back to India, ten odd days later, there was a huge earthquake there. So we got fairly lucky. As soon as I came back from Croatia, I was supposed to go back to Palm Springs in Miami, and it was cancelled. Then the French Open got postponed, Wimbledon cancelled.

I think, at the moment, I am concentrating on reinventing myself with other businesses. It is very hard that all our careers, our jobs have come to a standstill, especially in sport. Even when the lockdown opens up because we are a global sport, we have to travel all over the world 99 per cent of my work is outside India. I feel that in itself makes it very hard where even after the lockdown opens up.

I humbly feel that there is not going to be any tennis till January 2021. Hence I have got to reinvent myself this whole year. We are only sitting in May right now, we have got all of May, June, July, the whole summer, whole of American summer. We are probably going to miss all three Grand Slams, miss an Olympics this year. So with the Olympics postponed to 2021, I think post the lockdown or towards the end of the year, as things start opening up for tennis, we (my team and I) will only reevaluate then as to whether I should continue next year or not.

Is this the longest youve been away from the court?

I have been blessed with such a long career and have rewritten the history books multiple times over. I am blessed to have won so much in all the four Grand Slams. Australian Open I think I have won four times, French Open four times, Wimbledon five times and the US Open five times. In the Davis Cup, I have the world record. I have an Olympic medal.

The reason it was my one last roar this year was that I felt I had already achieved everything and there were few things to play for. To participate in three more Grand Slams to get to 100 is a lifetime of sweat and toil and hard work. So I think that when you look back at my career, it was blessed.

I will always be playing tennis. I will be playing tennis in some shape or form. Whether it is seniors or exhibition, whether it is world team tennis or league, whether it is playing for fun with my family. I will always have tennis in my day-to-day lifestyle. In terms of professional tennis, that is something we have to evaluate at the end of the year.

Away from tennis, are you pursuing any other professional career?

There is so much else to do. I cant really speak about it right now but there is so much my team planned for the last three, four years. Right now in one context, this lockdown has given a realisation that I have to reinvent myself. So its very nice that I get to spend time with my family, get to enjoy quality time with them. I have never spent this much time at home in one long stretch as I have always been working for the last 20 years.

Forty weeks a year travelling and touring non-stop. So I am really taking advantage of this time, spending time with my family. That being said, in terms of other opportunities, businesses and other passions I have had, my team has been working for the last four-five years to put things together. I am spending time to get that done. Because all of these are large projects and they need time and require my personal attention. I am enjoying that.

Any particular lockdown moment you would love to remember? Cooking...

I love to cook. I enjoy different kinds of cuisine obviously. Travelling on the tour it becomes a necessity and also you dont usually have a kitchen everywhere you go. So I specialise in pasta and salad. Breakfast is one of my favourite meals. I can eat breakfast morning, noon or night. And I love making different kinds of breakfast. When it comes to serious cooking, those are the things I am really passionate about.

When I finish with my tennis, I want to learn serious cooking. Take cooking classes. They have a Michelin chef cooking class. French patisserie is very interesting. The way they bake and make bread and pastries. There are so many fun things to do that in one context. I am really looking forward to that time as well. I always maximise whatever position I am in. I always make the best of it. No restaurant though. Cooking for my loved ones for sure.

How many hours do you train? Motivation an issue?

About three hours. Motivation is an issue. It is very difficult. It is something we all have to take stock of. Especially since we are not allowed to leave the house, we should ensure we get plenty of movement. Otherwise, we just sit down in one position on our phones, in front of the computer, or reading, watching Netflix and videos.

There is so much out there that it is distracting. It is really important to get movement. Even if it is walking in a living room. One room to the other. Freehand exercises, core exercises, yoga meditation or breathing, now is the time to do. All professional athletes are doing a lot of fitness exercises. Sustainability is important. You have to be mentally and emotionally fresh.

Even after lockdown, it will take a few weeks before professional sports are back. Plenty of time to sustain fitness levels but the fact is that we are not getting to play football, cricket, badminton or tennis now. Some tennis strokes might be a bit rusty. It might take a bit longer to fix that.

Which is your most cherished moment? Grand Slam wins, Davis Cup matches/records or the Olympic medal?

So many cherished moments! Its hard to pick. If I had to pick my Davis Cup wins, there are so many. If I have to pick every one of my Davis Cup wins, those were very special because I got to play for the tiranga (tricolour). I played for 1.3 billion people. Every one of my Grand Slam victories, all of them with different partners are very special. Then if you look at beating Pete Sampras in singles in New Haven in 1998; beating Roger Federer in singles in Indian Wells in 2001; winning the Newport Hall of Fame in 1998 was special.

If I have to choose the most important one, that would be the Olympic bronze. That is really, really special. The first time they introduced the (Olympic) play-offs, it was quite a tough. Was to meet Sampras in the first round and most of my peers were saying draw was bad luck. But somehow, I felt Atlanta was magic. I worked my whole life for it. The day before the first match, Sampras had pulled out, they put Richey Reneberg (USA) in. So I beat him, then Nicholas Pereira in the second, then Thomas Enqvist and beat Renzo Furlan in quarters.

In the semis, I injured my wrist. Andre Agassi played a passing shot when he was down 5-6 and 15-40, I pushed the ball to his backhand and he hit it as hard as he could right at my face. I felt I had every shot covered except that one. When he did, my hand hurt so badly that I didnt realise until later that I had a tear in my wrist tendon. That was a tough one. I had to come back two days later to play Fernando Meligeni, one of my friends from Brazil. To play him in the bronze play-off was tough because he was in good form. I was down a set to him and then I came back and won. After years of hard work and perseverance, I could emulate what my dad did, win an Olympic medal for India.Parents role in sportspersons development?

Parents have a huge role to play. That emotional fitness starts with parents. It is also important to know that the coaches the parents choose are very crucial. When you choose the right team, you choose the right coach, right fitness trainer. It is important to let the coaches do their job.

The parents do not have to be the coach. They dont have to be the fitness trainer or the physiotherapist. The parent needs to be the confidante. Parents can be the handling companion, support system. The unconditional love every parent gives is something every child needs. Its a huge support. I am what I am is because of my parents. I am so blessed. I have an unbelievable support system and Im lucky. Not only the genetics but all the skills they have taught.

On frying pan challenge and Mahesh Bhupathi

Its all about hand-eye coordination. Its not so difficult when you are a professional athlete. Mahesh Bhupathi and I have had some good banter. We stay in touch and its nice that we can communicate and bring some happiness to people especially in a time like this when it is needed.

See the rest here:
INTERVIEW | Leander Paes and the art of reinventing during lockdown - The New Indian Express

Global Precision Medicine Software Market: Trends Estimates High Demand by 2027

The Precision Medicine Software Market 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Precision Medicine Software Industry Report is an in-depth study analyzing the current state of the Precision Medicine Software Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Precision Medicine Software Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape.

It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Precision Medicine Software market. All findings and data on the global Precision Medicine Software market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Precision Medicine Software market available in different regions and countries.

The final report will add the analysis of the Impact of Covid-19 in this report Precision Medicine Software industry.

Some of the companies competing in the Precision Medicine Software markets are: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health

Get a Free Sample [emailprotected] https://www.reportsandmarkets.com/sample-request/global-precision-medicine-software-market-2019-by-company-regions-type-and-application-forecast-to-2024

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the Precision Medicine Software Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and development plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

Global Precision Medicine Software Market Research Report 2020 carries in-depth case studies on the various countries which are involved in the Precision Medicine Software market. The report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the market. Important contents analyzed and discussed in the report include market size, operation situation, and current & future development trends of the market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

What questions does the Precision Medicine Software market report answer pertaining to the regional reach of the industry

The report claims to split the regional scope of the Precision Medicine Software market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration

How do the sales figures look at present How does the sales scenario look for the future

Considering the present scenario, how much revenue will each region attain by the end of the forecast period

How much is the market share that each of these regions has accumulated presently

How much is the growth rate that each topography will depict over the predicted timeline

A short overview of the Precision Medicine Software market scope:

Global market remuneration

Overall projected growth rate

Industry trends

Competitive scope

Product range

Application landscape

Supplier analysis

Marketing channel trends Now and later

Sales channel evaluation

Market Competition Trend

Market Concentration Rate

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

TABLE OF CONTENT:

Chapter 1:Precision Medicine Software Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3:Precision Medicine Software Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Precision Medicine Software Market Effect Factors Analysis

Chapter 12: GlobalPrecision Medicine Software Market Forecast to 2027

Get Complete Report @ https://www.reportsandmarkets.com/sample-request/global-precision-medicine-software-market-2019-by-company-regions-type-and-application-forecast-to-2024

About Us:

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

The rest is here:
Precision Medicine Software Market to See Massive Growth by 2026| Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation...

Latest Report On Adrenomyeloneuropathy Treatment Market including Market Landscape, and Market size, Revenues by players, Revenues by regions, Average prices, Competitive landscape, market Dynamics and industry trends and developments during the forecast period.

The global Adrenomyeloneuropathy Treatment market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Adrenomyeloneuropathy Treatment market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global market. The authors of the report profile leading companies of the global Adrenomyeloneuropathy Treatment market, Also the details about important activities of leading players in the competitive landscape.

Key companies operating in the global Adrenomyeloneuropathy Treatment market include: :, Ascend Biopharmaceuticals, Novadip Biosciences, Eureka Therapeutics, Human Longevity, Regeneus, Allogene Therapeutics, BioRestorative Therapies, Immatics Biotechnologies, NewLink Genetics, Cytori Therapeutics, Talaris Therapeutics

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1664172/global-adrenomyeloneuropathy-treatment-market

The report predicts the size of the global Adrenomyeloneuropathy Treatment market in terms of value and volume for the forecast period 2020-2026. As per the analysis provided in the report, the global Adrenomyeloneuropathy Treatment market is expected to rise at a CAGR of xx % between 2020 and 2026 to reach a valuation of US$ xx million/billion by the end of 2026. In 2020, the global Adrenomyeloneuropathy Treatment market attained a valuation of US$ XX million/billion. The market researchers deeply analyze the global Adrenomyeloneuropathy Treatment industry landscape and the future prospects it is anticipated to create

Segmental Analysis

The report has classified the global Adrenomyeloneuropathy Treatment industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Adrenomyeloneuropathy Treatment manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Adrenomyeloneuropathy Treatment industry.

Global Adrenomyeloneuropathy Treatment Market Segment By Type:

, Steroid Replacement Therapy, Stem Cell Transplant By the end users,

Global Adrenomyeloneuropathy Treatment Market Segment By Application:

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Adrenomyeloneuropathy Treatment market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Adrenomyeloneuropathy Treatment industry. Based on our recent survey, we have several different scenarios about the Adrenomyeloneuropathy Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Adrenomyeloneuropathy Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. Global Adrenomyeloneuropathy Treatment market: Drivers and Restraints This section covers the various factors driving the global Adrenomyeloneuropathy Treatment market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by value and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market. Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market. Global Adrenomyeloneuropathy Treatment market: Segment Analysis The global Adrenomyeloneuropathy Treatment market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided revenue according to the consumption of the product. Global Adrenomyeloneuropathy Treatment market: Regional Analysis The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026. Global Adrenomyeloneuropathy Treatment market: Key Players The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market. By the therapy, the market is primarily split into, Steroid Replacement Therapy, Stem Cell Transplant By the end users, Hospitals, Clinics, Ambulatory Surgical Centers, Others

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Adrenomyeloneuropathy Treatment industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Adrenomyeloneuropathy Treatment market include: :, Ascend Biopharmaceuticals, Novadip Biosciences, Eureka Therapeutics, Human Longevity, Regeneus, Allogene Therapeutics, BioRestorative Therapies, Immatics Biotechnologies, NewLink Genetics, Cytori Therapeutics, Talaris Therapeutics

Key questions answered in the report:

Enquire for Customization in the report @ https://www.qyresearch.com/customize-request/form/1664172/global-adrenomyeloneuropathy-treatment-market

TOC

1 Market Overview of Adrenomyeloneuropathy Treatment1.1 Adrenomyeloneuropathy Treatment Market Overview1.1.1 Adrenomyeloneuropathy Treatment Product Scope1.1.2 Market Status and Outlook1.2 Global Adrenomyeloneuropathy Treatment Market Size Overview by Region 2015 VS 2020 VS 20261.3 Global Adrenomyeloneuropathy Treatment Market Size by Region (2015-2026)1.4 Global Adrenomyeloneuropathy Treatment Historic Market Size by Region (2015-2020)1.5 Global Adrenomyeloneuropathy Treatment Market Size Forecast by Region (2021-2026)1.6 Key Regions Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.6.1 North America Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.6.2 Europe Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.6.3 China Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.6.4 Rest of Asia Pacific Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.6.5 Latin America Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.6.6 Middle East & Africa Adrenomyeloneuropathy Treatment Market Size YoY Growth (2015-2026)1.7 Coronavirus Disease 2019 (Covid-19): Adrenomyeloneuropathy Treatment Industry Impact1.7.1 How the Covid-19 is Affecting the Adrenomyeloneuropathy Treatment Industry

1.7.1.1 Adrenomyeloneuropathy Treatment Business Impact Assessment Covid-19

1.7.1.2 Supply Chain Challenges

1.7.1.3 COVID-19s Impact On Crude Oil and Refined Products1.7.2 Market Trends and Adrenomyeloneuropathy Treatment Potential Opportunities in the COVID-19 Landscape1.7.3 Measures / Proposal against Covid-19

1.7.3.1 Government Measures to Combat Covid-19 Impact

1.7.3.2 Proposal for Adrenomyeloneuropathy Treatment Players to Combat Covid-19 Impact 2 Adrenomyeloneuropathy Treatment Market Overview by Therapy2.1 Global Adrenomyeloneuropathy Treatment Market Size by Therapy: 2015 VS 2020 VS 20262.2 Global Adrenomyeloneuropathy Treatment Historic Market Size by Therapy (2015-2020)2.3 Global Adrenomyeloneuropathy Treatment Forecasted Market Size by Therapy (2021-2026)2.4 Steroid Replacement Therapy2.5 Stem Cell Transplant 3 Adrenomyeloneuropathy Treatment Market Overview by Therapy3.1 Global Adrenomyeloneuropathy Treatment Market Size by End Users: 2015 VS 2020 VS 20263.2 Global Adrenomyeloneuropathy Treatment Historic Market Size by End Users (2015-2020)3.3 Global Adrenomyeloneuropathy Treatment Forecasted Market Size by End Users (2021-2026)3.4 Hospitals3.5 Clinics3.6 Ambulatory Surgical Centers3.7 Others 4 Global Adrenomyeloneuropathy Treatment Competition Analysis by Players4.1 Global Adrenomyeloneuropathy Treatment Market Size (Million US$) by Players (2015-2020)4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenomyeloneuropathy Treatment as of 2019)4.3 Date of Key Manufacturers Enter into Adrenomyeloneuropathy Treatment Market4.4 Global Top Players Adrenomyeloneuropathy Treatment Headquarters and Area Served4.5 Key Players Adrenomyeloneuropathy Treatment Product Solution and Service4.6 Competitive Status4.6.1 Adrenomyeloneuropathy Treatment Market Concentration Rate4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data5.1 Ascend Biopharmaceuticals5.1.1 Ascend Biopharmaceuticals Profile5.1.2 Ascend Biopharmaceuticals Main Business and Companys Total Revenue5.1.3 Ascend Biopharmaceuticals Products, Services and Solutions5.1.4 Ascend Biopharmaceuticals Revenue (US$ Million) (2015-2020)5.1.5 Ascend Biopharmaceuticals Recent Developments5.2 Novadip Biosciences5.2.1 Novadip Biosciences Profile5.2.2 Novadip Biosciences Main Business and Companys Total Revenue5.2.3 Novadip Biosciences Products, Services and Solutions5.2.4 Novadip Biosciences Revenue (US$ Million) (2015-2020)5.2.5 Novadip Biosciences Recent Developments5.3 Eureka Therapeutics5.5.1 Eureka Therapeutics Profile5.3.2 Eureka Therapeutics Main Business and Companys Total Revenue5.3.3 Eureka Therapeutics Products, Services and Solutions5.3.4 Eureka Therapeutics Revenue (US$ Million) (2015-2020)5.3.5 Human Longevity Recent Developments5.4 Human Longevity5.4.1 Human Longevity Profile5.4.2 Human Longevity Main Business and Companys Total Revenue5.4.3 Human Longevity Products, Services and Solutions5.4.4 Human Longevity Revenue (US$ Million) (2015-2020)5.4.5 Human Longevity Recent Developments5.5 Regeneus5.5.1 Regeneus Profile5.5.2 Regeneus Main Business and Companys Total Revenue5.5.3 Regeneus Products, Services and Solutions5.5.4 Regeneus Revenue (US$ Million) (2015-2020)5.5.5 Regeneus Recent Developments5.6 Allogene Therapeutics5.6.1 Allogene Therapeutics Profile5.6.2 Allogene Therapeutics Main Business and Companys Total Revenue5.6.3 Allogene Therapeutics Products, Services and Solutions5.6.4 Allogene Therapeutics Revenue (US$ Million) (2015-2020)5.6.5 Allogene Therapeutics Recent Developments5.7 BioRestorative Therapies5.7.1 BioRestorative Therapies Profile5.7.2 BioRestorative Therapies Main Business and Companys Total Revenue5.7.3 BioRestorative Therapies Products, Services and Solutions5.7.4 BioRestorative Therapies Revenue (US$ Million) (2015-2020)5.7.5 BioRestorative Therapies Recent Developments5.8 Immatics Biotechnologies5.8.1 Immatics Biotechnologies Profile5.8.2 Immatics Biotechnologies Main Business and Companys Total Revenue5.8.3 Immatics Biotechnologies Products, Services and Solutions5.8.4 Immatics Biotechnologies Revenue (US$ Million) (2015-2020)5.8.5 Immatics Biotechnologies Recent Developments5.9 NewLink Genetics5.9.1 NewLink Genetics Profile5.9.2 NewLink Genetics Main Business and Companys Total Revenue5.9.3 NewLink Genetics Products, Services and Solutions5.9.4 NewLink Genetics Revenue (US$ Million) (2015-2020)5.9.5 NewLink Genetics Recent Developments5.10 Cytori Therapeutics5.10.1 Cytori Therapeutics Profile5.10.2 Cytori Therapeutics Main Business and Companys Total Revenue5.10.3 Cytori Therapeutics Products, Services and Solutions5.10.4 Cytori Therapeutics Revenue (US$ Million) (2015-2020)5.10.5 Cytori Therapeutics Recent Developments5.11 Talaris Therapeutics5.11.1 Talaris Therapeutics Profile5.11.2 Talaris Therapeutics Main Business and Companys Total Revenue5.11.3 Talaris Therapeutics Products, Services and Solutions5.11.4 Talaris Therapeutics Revenue (US$ Million) (2015-2020)5.11.5 Talaris Therapeutics Recent Developments 6 North America Adrenomyeloneuropathy Treatment by Players and by End Users6.1 North America Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)6.2 North America Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 7 Europe Adrenomyeloneuropathy Treatment by Players and by End Users7.1 Europe Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)7.2 Europe Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 8 China Adrenomyeloneuropathy Treatment by Players and by End Users8.1 China Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)8.2 China Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 9 Rest of Asia Pacific Adrenomyeloneuropathy Treatment by Players and by End Users9.1 Rest of Asia Pacific Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)9.2 Rest of Asia Pacific Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 10 Latin America Adrenomyeloneuropathy Treatment by Players and by End Users10.1 Latin America Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)10.2 Latin America Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 11 Middle East & Africa Adrenomyeloneuropathy Treatment by Players and by End Users11.1 Middle East & Africa Adrenomyeloneuropathy Treatment Market Size and Market Share by Players (2015-2020)11.2 Middle East & Africa Adrenomyeloneuropathy Treatment Market Size by End Users (2015-2020) 12 Adrenomyeloneuropathy Treatment Market Dynamics12.1 Industry Trends12.2 Market Drivers12.3 Market Challenges12.4 Porters Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Disclaimer14.4 Author List

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Here is the original post:
Adrenomyeloneuropathy Treatment Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026|...

Ammo Grrrll is thinking about the end in WHAT WILL GET YOU YOU JUST NEVER KNOW. She writes

Im afraid I have some bad news, dear readers. I think Steve Martin put it best when last I heard him in concert 40 some years ago. Near the end of his flawless and hilarious standup set, he said, Well, I think weve all managed to have a pretty good time tonightconsidering were all going to die.

Yes, in the midst of trying to figure out what the mortality rate is for the Wuhan Virus when we have no damn idea what the denominator is, I must remind you that the mortality rate for everyone currently alive is 100%. I know. Bummer. It appears that the underlying condition that guarantees eventual death is being mortal. Who knew?

And so we must do the best we can to make what time we have count. Love God and your fellow humans; eat often and well; laugh a lot; do something useful and productive; connect with friends; have some babies; be kind; try to stay healthy and happy.

It appears that the cunning plan I had to avoid the death that took my maternal Grandfather when I was six I just wont close my eyes may be ineffective after all. On the other hand, my plan to be blessed with good genetics for longevity is panning out nicely. My other three grandparents lived well into my early adulthood and my own parents both lived to 95, with Daddy still soldiering on, going for a family record. His paternal grandmother lived to be a thorn in her daughter-in-laws side to the age of 96. She was a rock-ribbed Republican who received an autographed framed photo of President Kennedy on the occasion of her 90th birthday. She hung it in a closet. Face to the wall. After he was murdered, she did face it front, out of respect, but it remained in the closet.

But back to our cheery subject at hand death. So, a couple of weeks ago, early evening, I dutifully donned my outdoor mask (homemade out of a festive cloth napkin and two matching hair scrunchies) and took off for the quarter-mile round trip hike to our group mailboxes. When what to my wondering eyes did appear, but a huge gaggle of neighbor ladies, a few men, not one of whom was the Magical Six Feet from another, four firetrucks, four police vehicles and an ambulance. Yikes! All the First Responders sported more long gloves than Southern girls on a homecoming float.

I did not spot the problem immediately, but when I did, I jumped about two feet and possibly blurted out a bad word! Because there was a small white Ford SUV sideways on the rock and cactus strewn lawn of the house at the end of our street. The vehicle had been stopped only by the house itself or it might have gone all the way to Casa Grande. By the grace of God, the occupants of the house were not in the part of the house that was smashed into. Structural damage is such that the poor residents cannot live in it for three to six months. And thats IF the Wuhan Woes do not prevent handymen from getting access to the property. And IF building materiel is in stock! Amazingly, the driver was not seriously injured.

So here we geezers all are, worried about an unpleasant, sometimes lethal virus. We are hiding in our houses with masks, gloves, hand sanitizer, and 300 rolls of toilet paper. Then it turns out that our house is the least safe place we could be when a deranged old lady Joe Bidens somewhat less senile sister? guns her vehicle and, with a long blocks running start, rams it full speed into our abode. What are the chances?

Meanwhile, controversial reports appear that suggest that house-hiding is actually preventing the herd immunity that apparently is a good thing, and the reason your Mom made you go play with the kids you didnt even like who had the Chicken Pox.

We just dont know what will get us and that makes us anxious and crabby. Its a capricious world. A high school classmate did two tours in Vietnam, came home to our safe little Minnesota village, and ran off the road and hit a tree. Killed instantly.

On the other hand, when my aunt was in her 60s, she had a routine complete checkup at Mayo Clinic in Rochester. She was shocked when a doctor told her she had an inoperable heart valve issue that would likely lead to her death within two years. Naturally, she found this news very upsetting and spent most of those two years being anxious and depressed. It turned out that that doctor was only off by a couple of decades, so no harm, no foul. She died a few weeks before she turned 90. It wasnt even from the heart valve, but from a fall.

Respected medical personnel flaunting medical degrees in stuff like epidemiology and infectious diseases and never forget that SOMEBODY was last in every class at med school tell us that we have a couple of options: EITHER we have to test 330 million people twice a day, minimum, before we can ever go eat in restaurants again OR, maybe we must all hide under our beds until nobody anywhere on Planet Earth ever has the Wuhan Flu again. Your mileage may vary, as it did with the prediction by Walzing Matilda, Minnesota Governor, that he was determined to lower the anticipated Minnesota deaths from 74,000 to 50,000 by destroying the economy. So far, there have been 343 deaths, so, well done there!

It may seem like a trivial point to some, but when your government lets out hardened and dangerous criminals so they dont get flu very nearly including the Green River serial killer who murdered 48 women but sends undercover sting operatives to suss out illegal nail painters and hairdressers, it may be time for a massive coordinated march on every statehouse. With masks and gloves and six feet apart, it goes without saying. Heck, Antifa already has set the precedent with masks.

Where would you be more safe than in a nail salon where the nail lady is wearing a mask?

My hair takes care of itself. It is in a long ponytail held by one of 10,000 scrunchies I own in vibrant colors. Its color is what some might erroneously call Grey when it is clearly Platinum Blonde. My husbands hair, on the other hand, is beginning to bear more than a slight resemblance to Buckwheats. Or Albert Einsteins. But you know whose hair is perfectly coifed and colored? Every single moronic news-head and politician! What a lucky coincidence.

Evidently, THEIR hairdressers are Essential Personnel, but ours can go fly a kite. Just not outdoors. Alone. On a beach. Ya basta! Enough, already! Let our people go. Out.

The rest is here:
Thoughts from the ammo line - Power Line